Immutep tweet: In this next series of #SITC21 videos, AIPAC Principal Investigator, Dr Hans Wildiers MD PhD of Uni Hospitals Leuven explains the MoA of efti when used with chemotherapy in HR+ / HER2- metastatic breast cancer patients.#LAG3 #immunotherapy #oncology
Media, page-71
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.5¢ |
Change
-0.015(4.55%) |
Mkt cap ! $458.1M | |||
| Open | High | Low | Value | Volume |
| 32.5¢ | 32.5¢ | 31.0¢ | $1.029M | 3.271M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 51296 | 31.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 30000 | 1 |
View Market Depth
| Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |